Cancer heterogeneity: implications for targeted therapeutics. - Wikidata - wikimedia - TriplyDB

Cancer heterogeneity: implications for targeted therapeutics.

Cancer heterogeneity: implications for targeted therapeutics.

http://www.wikidata.org/entity/Q34321565

about

The Quest for Targets Executing MYC-Dependent Cell Transformation Tumour Cell Heterogeneity The urgent need to recover MHC class I in cancers for effective immunotherapy Overview of current immunotherapeutic strategies for glioma Therapeutic strategies targeting cancer stem cells Cell injury, retrodifferentiation and the cancer treatment paradox Translational implications of tumor heterogeneity In vivo molecular imaging of cancer stem cells Fluorescent imaging of cancerous tissues for targeted surgery.SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis Bridging the gap between clinicians and systems biologists: from network biology to translational biomedical research Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer Molecular heterogeneity in glioblastoma: potential clinical implications Tracking genomic cancer evolution for precision medicine: the lung TRACERx study In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnostics Translating neoadjuvant therapy into survival benefits: one size does not fit all.Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.Integrative gene set analysis of multi-platform data with sample heterogeneity.Image-guided genomics of phenotypically heterogeneous populations reveals vascular signalling during symbiotic collective cancer invasion.Pathway-Informed Classification System (PICS) for Cancer Analysis Using Gene Expression Data.Rational design of non-resistant targeted cancer therapies Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity.Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer Complexity and algorithms for copy-number evolution problems.Design and applications of bispecific heterodimers: molecular imaging and beyond Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives.Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.The Repurposing Drugs in Oncology (ReDO) Project.Competing views on cancer.Biased estimates of clonal evolution and subclonal heterogeneity can arise from PCR duplicates in deep sequencing experiments.Meta-analysis of expression of l(3)mbt tumor-associated germline genes supports the model that a soma-to-germline transition is a hallmark of human cancers Single-cell Western blotting after whole-cell imaging to assess cancer chemotherapeutic response.CDK7-dependent transcriptional addiction in triple-negative breast cancer.Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis.Antioxidant, Anti-inflammatory, and Genomic Stability Enhancement Effects of Zinc l-carnosine: A Potential Cancer Chemopreventive Agent?Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome.Therapeutic melting pot of never in mitosis gene a related kinase 2 (Nek2): a perspective on Nek2 as an oncology target and recent advancements in Nek2 small molecule inhibition Identification of novel microRNA regulatory pathways associated with heterogeneous prostate cancer.Quantification of heterogeneity as a biomarker in tumor imaging: a systematic review

P2860

Q26744579-557E76E0-8956-4233-A5D1-9387C482B570 Q26765895-5D04E0F4-2372-469F-8513-6FF89AE1B820 Q26770165-C683E908-5C11-4084-8038-C3F00DB1F831 Q26776345-0E288B93-1DB3-4419-883A-37DD86AC9D37 Q26781398-5C377DBE-69D1-4E1C-97CF-D00212340631 Q26783201-73EDD12D-800A-43BF-9D50-09234051251B Q26822823-BB879BA8-A97D-4C42-963C-6C0F29131FCE Q26828630-CEEEDFDE-0481-43A4-8DD2-18ED78DB73FA Q26830905-A56C903F-B7EE-4A77-8B85-2E9994EBB512 Q27321859-370CCFEC-0747-412A-A154-61A5E8B1BFCA Q28066914-6BB554DD-0686-47C6-AE6C-ED33A7816642 Q28072766-D8CE7ACB-F836-46CE-B4E2-0169ADDE0C1B Q28084216-69E51E30-AF19-4893-8FC5-3638A6405FF2 Q28088605-9F743B31-2DCF-4E22-9E2D-FA52F9532BAB Q28655985-235EEFC3-D8B2-4227-AF81-EAC57FEAECA6 Q28658975-22EA23E5-BBA3-4EC1-81E0-17D67560284F Q30251738-A10B552B-0D49-4C5F-85C9-7C9B923C2B08 Q30368396-8FD5FF23-F24C-4B5D-A7B9-C24D8093945C Q30747009-B85F1215-B222-4A15-AFD0-FB377C1306A8 Q30851875-67DBEF89-4443-49FB-83A7-14827908489E Q31119292-DBC29464-D20B-4C58-861F-B8FFE8288B9C Q33594692-C1002E68-794C-4A55-85E3-7EDFA66BDA98 Q33607816-64C40180-D6F9-4CF4-9C0B-EA37DDEE1652 Q33631430-6A1957C6-1C75-444A-8B3E-F90416EB8048 Q33691886-CF92179A-5A29-46CB-9F85-B4BA5C02C214 Q33732587-D90925E7-79AF-40CA-9914-56B7BB3574AF Q33738675-9B243DF1-0505-400E-B452-04D5E03F6FBE Q33806957-38108A39-E831-4B66-BCA0-43D62F2200AA Q33893949-AEE7B53A-9F86-4BA4-B195-A80FC390B32A Q34060169-722DDD23-5BF4-428A-B788-160A24F7F300 Q34193443-F8516754-D23C-4406-9A31-48763343AE53 Q34200595-69D4C7E3-D3BD-42B9-8232-084227BBFD41 Q34379843-059E8E7F-14D1-481F-8233-2E00B34AA483 Q34495729-29EA802F-6411-4D2F-B331-972854F1C995 Q34547261-D9BB60DA-7969-49F3-BA68-D9C194527666 Q34549429-B70BB99E-C222-4907-B262-533A58EEE998 Q34815370-24E3F94D-E450-44BA-867B-617FEC4CE345 Q35092019-BE0B1BBB-1176-47FD-9187-B8835D9080F4 Q35098669-E3865D11-7B22-4231-8B97-9D7BA3C8C005 Q35350679-FC0AD0B5-0FB3-4815-9B78-50DE981D54C6

P2860

Cancer heterogeneity: implications for targeted therapeutics.

http://www.wikidata.org/entity/Q34321565

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Cancer heterogeneity: implications for targeted therapeutics.

@ast

Cancer heterogeneity: implications for targeted therapeutics.

@en

Cancer heterogeneity: implications for targeted therapeutics.

@nl

type

label

Cancer heterogeneity: implications for targeted therapeutics.

@ast

Cancer heterogeneity: implications for targeted therapeutics.

@en

Cancer heterogeneity: implications for targeted therapeutics.

@nl

prefLabel

Cancer heterogeneity: implications for targeted therapeutics.

@ast

Cancer heterogeneity: implications for targeted therapeutics.

@en

Cancer heterogeneity: implications for targeted therapeutics.

@nl

P1433

Q34321565-29BC767A-78B4-488C-98AE-3C07E8A3729F

P1476

Q34321565-48D029F0-98B7-4050-A40B-119E3FE79109

P2093

Q34321565-921DAD50-375F-46BB-99F9-46B3D9143917

Q34321565-D8E462DD-F42F-4ED5-9067-53F9A253A92D

P275

Q34321565-5E7CD091-361A-41A3-A1B0-2C29AEE43A0E

P2860

Q34321565-014A3A03-49E7-40AD-87B3-AECDB99596CA

Q34321565-038264CD-1857-4516-8F16-40E4254854B9

Q34321565-0900AE4B-3D80-48D5-AA72-7355EE20436C

Q34321565-0A05B92A-7163-421A-9643-A16E169B4908

Q34321565-0A1CFD06-68DB-498A-A2D9-E7FC706FD63F

Q34321565-0B27C825-F2B4-4038-A130-C4180D7801A7

Q34321565-18762750-493B-46B1-81BE-CD7F314BFE4F

Q34321565-18BCCA3F-62C3-453C-9CF4-4D00A172AC14

Q34321565-1F63CBCC-C3E0-4FF8-A00A-67CF42605E8A

Q34321565-23937116-574A-4DCB-BEDB-4D2E930A2EE2

P2888

Q34321565-8435301C-BE4B-4976-BB34-B608E631BC9F

P304

Q34321565-A81499AC-01C0-406D-A99A-F3A7B3C843D8

P31

Q34321565-677C0BDE-8867-42F3-BC4F-EE185F533E2D

Q34321565-DB38C590-A9A3-4522-896A-70705E4B87ED

P356

Q34321565-59082D68-1BD4-48AF-A8CD-ECCC4CECB3E6

P407

Q34321565-12F2C52E-FEAD-45A5-9464-C7870B1630AD

P433

Q34321565-465D31B5-806F-4C3B-A1D2-E3ADB05311C8

P478

Q34321565-73FFFC12-A310-48D0-8E84-248C269FFC5D

P50

Q34321565-911EA061-6106-4ABC-8E36-3C8BF20BB200

P5008

Q34321565-0EF57E14-5A95-4A2B-A812-6C28A07BAB94

P577

Q34321565-6120EC93-166D-4E0E-B123-5D733B0FD192

Q34321565-8395722D-5F86-483C-9F39-A2C5AD73CE64

P5875

Q34321565-2EFC1ADD-378A-4572-927B-91D261088504

P6179

Q34321565-3CDAC1BB-9AC9-4C5A-9A1A-0134DA2F65B6

P698

Q34321565-BB9B1645-43E6-47BF-B45C-3D0A5E50D311

P921

Q34321565-35622C6D-3AE6-4193-B5B3-6856FDCC61A7

Q34321565-DD62167C-003C-4273-9226-1229C8707987

P932

Q34321565-D03C6BE8-279C-4400-986B-31DF15CA232E

P356

P1433

British Journal of Cancer

P1476

Cancer heterogeneity: implications for targeted therapeutics.

@en

P2093

L Pusztai

http://www.w3.org/2001/XMLSchema#string

R Fisher

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

P2860

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Whole-genome analysis informs breast cancer response to aromatase inhibition

The clonal evolution of tumor cell populations

Cancer in light of experimental evolution

Inferring tumor progression from genomic heterogeneity

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

P2888

P304

479-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2012.581

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Charles Swanton

P5008

P577

2013-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234089187

http://www.w3.org/2001/XMLSchema#string

P6179

1028324691

http://www.w3.org/2001/XMLSchema#string

P698

23299535

http://www.w3.org/2001/XMLSchema#string

P921

genetic variation

P932

3593543

http://www.w3.org/2001/XMLSchema#string